Septerna (SEPN) Amortizatization of Intangibles (2024 - 2026)
Septerna's quarterly Amortizatization of Intangibles came in at $755000.0 in Q1 2026, down 21.76% year-on-year from $965000.0 in Q1 2025, and down 14.88% quarter-over-quarter from $887000.0 in Q4 2025.
Septerna has reported Amortizatization of Intangibles for 3 years, with the latest figure at $755000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 21.76% year-over-year to $755000.0; the trailing twelve-month figure through Mar 2026 stood at $3.2 million (up 40.6% YoY), and the FY2025 full-year result was $3.4 million, up 144.54% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $755000.0, down from $887000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $975000.0 in Q2 2025, with the low at $72000.0 in Q1 2024.
- Average Amortizatization of Intangibles over 3 years is $623666.7, with a median of $755000.0 recorded in 2026.
- Year-over-year, Amortizatization of Intangibles jumped 1240.28% in 2025 and slipped 21.76% in 2026.
- Tracing SEPN's Amortizatization of Intangibles over 3 years: stood at $809000.0 in 2024, then increased by 9.64% to $887000.0 in 2025, then slipped by 14.88% to $755000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $755000.0 (Q1 2026), $887000.0 (Q4 2025), and $621000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Septerna | 1.34 Bn | 1.34 Bn | - | 755,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 755,000.00 |
| Mar 31, 2026 | 755,000.00 |
| Dec 31, 2025 | 887,000.00 |
| Dec 31, 2025 | 887,000.00 |
| Sep 30, 2025 | 621,000.00 |
| Sep 30, 2025 | 621,000.00 |
| Jun 30, 2025 | 975,000.00 |
| Jun 30, 2025 | 975,000.00 |
| Mar 31, 2025 | 965,000.00 |
| Mar 31, 2025 | 965,000.00 |
| Dec 31, 2024 | 809,000.00 |
| Dec 31, 2024 | 809,000.00 |
| Sep 30, 2024 | 371,000.00 |
| Sep 30, 2024 | 371,000.00 |
| Jun 30, 2024 | 158,000.00 |
| Jun 30, 2024 | 158,000.00 |
| Mar 31, 2024 | 72,000.00 |
| Mar 31, 2024 | 72,000.00 |